| |
| |
|
| Insider
Information: |
Myszkowski Kenneth Allen |
| Relationship: |
Chief Financial Officer |
| City: |
Pasadena |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
400,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,922,862 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
400,600 |
|
|
| Total
Value |
$9,922,862 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -102.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arrowhead Pharmaceuticals Inc |
ARWR |
Chief Financial Officer |
2024-03-06 |
400,600 |
2010-08-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-05-30 |
4 |
OE |
$2.01 |
$2,814 |
D/D |
1,400 |
312,215 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-05-30 |
4 |
AS |
$11.00 |
$15,400 |
D/D |
(1,400) |
310,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
S |
$81.00 |
$116,721 |
D/D |
(1,441) |
444,005 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-03-04 |
4 |
D |
$4.33 |
$27,119 |
D/D |
(6,263) |
115,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-08-23 |
4 |
OE |
$2.01 |
$13,869 |
D/D |
6,900 |
122,589 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-08-23 |
4/A |
AS |
$8.00 |
$55,200 |
D/D |
(6,900) |
115,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-08-23 |
4 |
S |
$8.00 |
$55,200 |
D/D |
(6,900) |
115,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-02-19 |
4 |
OE |
$5.20 |
$41,600 |
D/D |
8,000 |
313,607 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-02-19 |
4 |
AS |
$18.00 |
$144,000 |
D/D |
(8,000) |
305,607 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-03-05 |
4 |
D |
$6.66 |
$54,665 |
D/D |
(8,208) |
310,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-01-02 |
4 |
AS |
$11.98 |
$99,829 |
D/D |
(8,333) |
387,482 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2021-01-11 |
4 |
S |
$81.02 |
$939,589 |
D/D |
(11,597) |
445,446 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
OE |
$2.01 |
$25,326 |
D/D |
12,600 |
323,415 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
AS |
$11.00 |
$138,600 |
D/D |
(12,600) |
310,815 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2019-11-05 |
4 |
OE |
$5.19 |
$65,648 |
D/D |
12,649 |
326,185 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-02-06 |
4 |
D |
$3.46 |
$45,146 |
D/D |
(13,048) |
121,952 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-08-22 |
4/A |
AS |
$8.00 |
$104,800 |
D/D |
(13,100) |
115,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-08-22 |
4 |
S |
$8.00 |
$104,800 |
D/D |
(13,100) |
115,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-08-22 |
4 |
OE |
$2.01 |
$26,331 |
D/D |
13,100 |
128,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2015-12-30 |
4 |
D |
$6.13 |
$80,628 |
D/D |
(13,153) |
108,347 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
CFO |
• – – |
2010-08-27 |
4 |
B |
$0.89 |
$13,350 |
D/D |
15,000 |
15,000 |
2.74 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2023-06-27 |
4 |
S |
$36.20 |
$543,000 |
D/D |
(15,000) |
381,704 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
CFO |
• – – |
2014-02-12 |
4 |
OE |
$2.01 |
$32,160 |
D/D |
16,000 |
87,500 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
CFO |
• – – |
2014-02-12 |
4 |
S |
$18.77 |
$300,290 |
D/D |
(16,000) |
71,500 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Financial Officer |
• – – |
2024-01-05 |
4 |
AS |
$34.04 |
$567,910 |
D/D |
(16,104) |
440,600 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
